These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2690609)

  • 1. Angiotensin-converting enzyme inhibition versus blockade of the renin-angiotensin system.
    Brunner HR; Waeber B; Nussberger J
    Am J Med; 1989 Dec; 87(6B):15S-18S. PubMed ID: 2690609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition.
    Mooser V; Nussberger J; Juillerat L; Burnier M; Waeber B; Bidiville J; Pauly N; Brunner HR
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):276-82. PubMed ID: 1689424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors.
    Borghi C; Boschi S; Ambrosioni E; Melandri G; Branzi A; Magnani B
    J Clin Pharmacol; 1993 Jan; 33(1):40-5. PubMed ID: 8429112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA; Derkx FH; van den Meiracker AH
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system.
    Hollenberg NK; Fisher ND; Price DA
    Hypertension; 1998 Sep; 32(3):387-92. PubMed ID: 9740600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma angiotensin II and the antihypertensive action of angiotensin-converting enzyme inhibition.
    Nussberger J; Waeber B; Brunner HR
    Am J Hypertens; 1989 Apr; 2(4):286-93. PubMed ID: 2650711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic interruption of the renin-angiotensin system and the kidney: differential responses to angiotensin-converting enzyme and renin inhibition.
    Hollenberg NK
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S239-42. PubMed ID: 9892171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal circulation and blockade of the renin-angiotensin system. Is angiotensin-converting enzyme inhibition the last word?
    Hollenberg NK; Fisher ND
    Hypertension; 1995 Oct; 26(4):602-9. PubMed ID: 7558219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosterone.
    Abdelrahman AM; Burrell LM; Johnston CI
    J Hypertens Suppl; 1993 Apr; 11(3):S23-6. PubMed ID: 8315514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of inhibitors of the renin-angiotensin system.
    Fouad-Tarazi FM
    J Hypertens Suppl; 1994 Jul; 12(2):S25-9. PubMed ID: 7965262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists.
    Campbell DJ
    Clin Exp Pharmacol Physiol Suppl; 1996; 3():S125-31. PubMed ID: 8993851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?
    Hollenberg NK
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
    Waeber B; Nussberger J; Juillerat L; Brunner HR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S53-9. PubMed ID: 2483430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.
    Brunner HR; Nussberger J; Waeber B
    J Hypertens Suppl; 1993 Apr; 11(3):S53-8. PubMed ID: 8315521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibition and renin inhibition.
    Nussberger J; Waeber B; Brunner HR
    J Hypertens Suppl; 1989 Apr; 7(2):S75-9. PubMed ID: 2666618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New angiotensin converting enzyme inhibitors. Their role in the management of hypertension.
    Laragh JH
    Am J Hypertens; 1990 Nov; 3(11):257S-265S. PubMed ID: 2261144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular renin-angiotensin system in hypertension. New insights into the mechanism of action of angiotensin converting enzyme inhibitors.
    Dzau VJ
    Am J Med; 1988 Apr; 84(4A):4-8. PubMed ID: 3218657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.